Should myeloid and lymphoid neoplasms withPCM1-JAK2and other rearrangements ofJAK2be recognized as specific entities?-Reference-Cited by-同舟云学术

Should myeloid and lymphoid neoplasms withPCM1-JAK2and other rearrangements ofJAK2be recognized as specific entities?

Published:2014-06-10 Issue:6 Volume:166 Page:809-817
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Bain Barbara J.¹,Ahmad Shahzaib²

Affiliation:

1. Department of Haematology; St Mary's Hospital Campus of Imperial College London; St Mary's Hospital; London UK

2. Barts and the London School of Medicine and Dentistry; Queen Mary University of London; St Batholomew's Hospital; London UK

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12963/fullpdf

Reference46 articles.

1. A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma;Adélaïde;Leukemia,2006

2. Chromosomal translocation t(9;22)(p24;q11) appears to be recurrently associated with myeloid malignancy with aggressive course;Angelova;Leukaemia & Lymphoma,2011

3. A combination of cytomorphology, cytogenetic analysis, fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction for establishing clonality in cases of persisting hypereosinophilia;Bacher;Haematologica,2006

4. Atypical chronic myeloid leukemia with t(9;22)(p24,11.2), a BCR-JAK2 fusion gene;Bellesso;Revista Brasileira de Hematologia e Hemoterapia,2013

5. The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene;Bousquet;Oncogene,2005

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Therapeutic Intervention of Hypereosinophilia in the Era of Molecular Diagnosis;Cancers;2024-03-31

2. Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage;Annals of Hematology;2024-02-03

3. The challenge of diagnosing and classifying eosinophilia and eosinophil disorders: A review;Central European Journal of Immunology;2024

4. Eosinophilia and the Hypereosinophilic Syndrome: Clinical, Molecular and Translational Aspects;Comprehensive Hematology and Stem Cell Research;2024

5. Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFCH);Current Research in Translational Medicine;2023-10